Loading...
Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
Recent advances in the treatment of early breast cancer have improved clinical outcomes and prolonged survival, especially in women with endocrine-responsive disease. However, cancer therapies including cytotoxic chemotherapy, ovarian suppression, and aromatase inhibitors can drastically reduce circ...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126000/ https://ncbi.nlm.nih.gov/pubmed/21789117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834009344594 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|